Streetbeat News

Analyst Ratings

HCA

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare (NYSE:HCA) and maintained a price target of $315.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:23 pm

ELV

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $547.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:21 pm

CI

Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on Cigna Group (NYSE:CI) and maintained a price target of $334.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:20 pm

T

AT&T Inc (NYSE:T) is expected to report Q4 results on Jan. 24, with positive outlook from Oppenheimer analyst Timothy Horan who upgraded the stock to Outperform with a $21 price target. Horan cites the company's transition to a pure connectivity provider, improved network, price increases on unlimited plans, and a high percentage of fiber broadband subscribers as key tailwinds. He also anticipates potential cost-saving synergies from a DirecTV merger and projects a 12% growth in free cash flows to $18.5 billion in fiscal 2024. AT&T shares rose by 1.46% to $16.65.

Portfolio Pulse from Priya Nigam

January 19, 2024 | 5:19 pm

GBTC

JPM

JPMorgan Chase & Co. analysts predict further outflows from Grayscale Bitcoin Trust (GBTC) due to high fees and competition from new spot Bitcoin ETFs. GBTC has already seen $1.5 billion in outflows and may face additional withdrawals of $1.5 billion. The bank's report suggests that GBTC's 1.5% management fee is too high compared to its peers, some of which offer zero fees. Other spot Bitcoin ETFs have seen $3 billion in inflows, indicating a shift from GBTC and futures-based ETFs.

Portfolio Pulse from Murtuza Merchant

January 19, 2024 | 5:18 pm

SPT

Stifel analyst Parker Lane has maintained a Buy rating on Sprout Social (NASDAQ:SPT) and increased the price target from $60 to $70.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:14 pm

NTR

Stifel analyst Vincent Anderson has reaffirmed a Buy rating on Nutrien (NYSE:NTR) and increased the price target from $72 to $75, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:13 pm

PLNT

Stifel analyst Chris O'Cull has reaffirmed a Buy rating on Planet Fitness (NYSE:PLNT) and increased the price target from $72 to $85, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:10 pm

MATX

Stifel analyst Benjamin Nolan has maintained a Hold rating on Matson (NYSE:MATX) and increased the price target from $102 to $108.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:07 pm

FUL

Stifel analyst Vincent Anderson has reaffirmed a Buy rating on H.B. Fuller (NYSE:FUL) and increased the price target from $110 to $115, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:06 pm